A analyze printed in JAMA Network Open up emphasizes the discrepancy among what it fees to generate copyright and the retail charges sufferers encounter. Despite the minimal output charges, Novo Nordisk has not publicly disclosed certain figures for copyright or its other products, Wegovy.Novo Nordisk is linked to governing administration funded co